Compositions and methods for enhanced expression of recombinant polypeptides from a single vector using a peptide cleavage site
View Patent ↗Vector constructs for expression of two or more functional proteins or polypeptides under operative control of a single promoter and methods of making and using the same are described. The vectors comprise a self-processing cleavage site between each respective protein or polypeptide coding sequence. The vector constructs include the coding sequence for a self-processing cleavage site and may further include an additional proteolytic cleavage sequence which provides a means to remove the self processing peptide sequence from expressed protein(s) or polypeptide(s). The vector constructs find utility in methods for enhanced production of biologically active proteins and polypeptides in vitro and in vivo.
1. An oligonucleotide construct for expression of a recombinant antibody or a recombinant antibody fragment having antigen-binding activity, wherein the antibody fragment is selected from the group consisting of Fab, F(ab′) 2 , Fv(scFv) and Fv antibody fragments, the oligonucleotide construct comprising, in the 5′ to 3′ direction, a promoter operably linked to all of (1) a coding sequence for a heavy chain of the antibody or a fragment of the heavy chain, (2) a coding sequence for a furin cleavage site, (3) a coding sequence for a 2A self-processing cleavage site and (4) a coding sequence for a light chain of the antibody or a fragment of the light chain.
2. The oligonucleotide construct of claim 1 wherein the 2A self-processing cleavage site is selected from the group consisting of SEQ ID NO:1, SEQ ID NO:2, SEQ ID NO:3, SEQ ID NO:4, SEQ ID NO:5, SEQ ID NO:6, SEQ ID NO:7, SEQ ID NO:8 and SEQ ID NO:9.
3. The oligonucleotide construct of claim 1 wherein the coding sequence for the 2A self processing cleavage site is SEQ ID NO:14.
4. The oligonucleotide construct of claim 1 wherein the 2A self processing cleavage site is SEQ ID NO:6.
5. The oligonucleotide construct of claim 1 wherein for the furin cleavage site has the consensus sequence SEQ ID NO:10.
6. The oligonucleotide construct of any one of claims 1 - 5 wherein the promoter is selected from the group consisting of an elongation factor 1-alpha promoter (EF1α) promoter, a phosphoglycerate kinase-1 promoter (PGK) promoter, a cytomegalovirus immediate early gene promoter (CMV), a chimeric liver-specific promoter (LSP), a cytomegalovirus enhancer/chicken beta-actin promoter (CAG), a tetracycline responsive promoter (TRE), a transthyretin promoter (TTR), a simian virus 40 promoter (SV40) and a CK6 promoter.